The following perpetrator compounds were selected:

- Mefenamic acid (UGT1A9 inhibitor)
- Atazanavir (UGT1A1 inhibitor)

The following sensitive substrates as victim drugs were selected:

- Dapagliflozin (UGT1A9)
- Raltegravir (UGT1A1)

A detailed description of the performed workflow in terms of DDI network modeling has been previously published ([Hanke 2018](# References)).